Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
COPD ; 15(4): 341-349, 2018.
Article in English | MEDLINE | ID: mdl-29799289

ABSTRACT

Hyperinflation, gas trapping and their responses to long-acting bronchodilator are clinically important in COPD. The forced oscillation technique (FOT) measures of respiratory system resistance and reactance are sensitive markers of bronchodilator response in COPD. The relationships between changes in resistance and reactance, and changes in hyperinflation and gas trapping, following long-acting bronchodilator (LA-BD) have not been studied. 15 subjects with mild-moderate COPD underwent FOT, spirometry then body plethysmography, before and 2 hours after a single 150 microg dose of the LA-BD indacaterol. Hyperinflation was quantified as the inspiratory capacity to total lung capacity ratio (IC/TLC), and gas trapping as residual volume to TLC ratio (RV/TLC). At baseline, FOT parameters were moderately correlated with IC/TLC (|r| 0.53-0.73, p < 0.05). At 2 hours post-LA-BD, there were moderate correlations between change in FOT and change in RV/TLC (|r| 0.60-0.82, p < 0.05). Baseline FOT parameters also correlated with the subsequent post-LA-BD change in both IC/TLC (|r| 0.54-0.62, p < 0.05) and RV/TLC (|r| 0.57-0.76, p < 0.05). FOT impedance reflects hyperinflation and gas trapping in COPD, and the potential for long-acting bronchodilator responsiveness. These results provide us with further insight into the physiological mechanisms of action of long-acting bronchodilator treatment, and may be clinically useful for predicting treatment responses.


Subject(s)
Bronchodilator Agents/therapeutic use , Indans/therapeutic use , Pulmonary Disease, Chronic Obstructive/drug therapy , Quinolones/therapeutic use , Aged , Airway Resistance/drug effects , Bronchodilator Agents/pharmacology , Diagnostic Techniques, Respiratory System , Female , Forced Expiratory Volume/drug effects , Humans , Indans/pharmacology , Male , Middle Aged , Oscillometry , Plethysmography, Whole Body , Pulmonary Diffusing Capacity/drug effects , Pulmonary Disease, Chronic Obstructive/physiopathology , Quinolones/pharmacology , Residual Volume/drug effects , Severity of Illness Index , Spirometry , Total Lung Capacity/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...